Bessemer Group Inc. Purchases 23,085 Shares of Agilent Technologies, Inc. $A

Bessemer Group Inc. increased its position in Agilent Technologies, Inc. (NYSE:A) by 2.6% in the 4th quarter, Holdings Channel reports. The firm owned 908,257 shares of the medical research company’s stock after buying an additional 23,085 shares during the quarter. Bessemer Group Inc.’s holdings in Agilent Technologies were worth $123,587,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Board of the Pension Protection Fund bought a new position in Agilent Technologies in the fourth quarter worth $27,000. Navalign LLC bought a new position in Agilent Technologies in the fourth quarter worth $27,000. Physician Wealth Advisors Inc. lifted its position in Agilent Technologies by 490.0% in the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after purchasing an additional 196 shares during the period. Torren Management LLC bought a new position in Agilent Technologies in the fourth quarter worth $32,000. Finally, State of Wyoming bought a new position in Agilent Technologies in the second quarter worth $35,000.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Wall Street Zen cut Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Barclays reduced their target price on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. UBS Group reduced their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Wells Fargo & Company dropped their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research note on Thursday, February 26th. Finally, Morgan Stanley dropped their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $163.71.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $111.69 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The stock has a fifty day moving average price of $115.06 and a two-hundred day moving average price of $130.68. Agilent Technologies, Inc. has a 52-week low of $107.07 and a 52-week high of $160.27. The firm has a market capitalization of $31.56 billion, a P/E ratio of 24.66, a P/E/G ratio of 2.38 and a beta of 1.22.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. During the same quarter in the prior year, the company earned $1.31 earnings per share. The business’s revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.